Evidence map›Paper›PMID 39017752›Full record

ArticleIn vitro cellular & developmental biology. Animal2024

Differentiation of SH-SY5Y neuroblastoma cells using retinoic acid and BDNF: a model for neuronal and synaptic differentiation in neurodegeneration.

Imogen L Targett, Lucy A Crompton, Myra E Conway, Tim J Craig

Abstract read
In one paragraph

Article in In vitro cellular & developmental biology. Animal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Imogen L TargettCentre for Research in Biosciences, School of Applied Sciences, University of the West of England, Bristol, BS16 1QY, UK.
Lucy A CromptonCentre for Research in Biosciences, School of Applied Sciences, University of the West of England, Bristol, BS16 1QY, UK.
Myra E ConwayUniversity of Derby, Derby, DE22 1GB, UK.
Tim J CraigCentre for Research in Biosciences, School of Applied Sciences, University of the West of England, Bristol, BS16 1QY, UK. tim.craig@uwe.ac.uk.ORCID http://orcid.org/0000-0002-5171-5204

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There has been much interest in the use of cell culture models of neurones, to avoid the animal welfare and cost issues of using primary and human-induced pluripotent stem cell (hiPSC)-derived neurones respectively. The human neuroblastoma cell line, SH-SY5Y, is extensively used in laboratories as they can be readily expanded, are of low cost and can be differentiated into neuronal-like cells. However, much debate remains as to their phenotype once differentiated, and their ability to recapitulate the physiology of bona fide neurones. Here, we characterise a differentiation protocol using retinoic acid and BDNF, which results in extensive neurite outgrowth/branching within 10 days, and expression of key neuronal and synaptic markers. We propose that these differentiated SH-SY5Y cells may be a useful substitute for primary or hiPSC-derived neurones for cell biology studies, in order to reduce costs and animal usage. We further propose that this characterised differentiation timecourse could be used as an in vitro model for neuronal differentiation, for proof-of principle studies on neurogenesis, e.g. relating to neurodegenerative diseases. Finally, we demonstrate profound changes in Tau phosphorylation during differentiation of these cells, suggesting that they should not be used for neurodegeneration studies in their undifferentiated state.

Indexed as

Brain-Derived Neurotrophic FactorCell DifferentiationNeuroblastomaNeuronsSynapsesTretinoinCell Line, TumorHumansModels, BiologicalNeurodegenerative DiseasesNeurogenesisPhosphorylationtau ProteinsBrain-Derived Neurotrophic Factortau ProteinsTretinoinCholinergicDifferentiationNeurodegenerationSH-SY5YSynaptic markers

Identifiers

PMID39017752
PMCPMC11534981

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.